医学
纤维化
叙述性评论
疾病
机会之窗
炎症
器官系统
病理
重症监护医学
肺纤维化
肺
全身性疾病
硬皮病(真菌)
特发性肺纤维化
生物信息学
肺纤维化
器官功能障碍
自身免疫性疾病
免疫学
类风湿性关节炎
肺病
炎症反应
作者
Alain Lescoat,Laura Ross,Christina Bergmann,Zsuzsanna Hortobagyi McMahan,Francesco Del Galdo,Mette Mogensen,Prachi P Agarwal,Tânia Santiago,Georg Andreas Schett,Giacomo Davide De Luca,Marco Matucci‐Cerinic,Yannick Allanore,Dinesh Khanna
出处
期刊:Rheumatology
[Oxford University Press]
日期:2026-07-31
卷期号:65 (9): keag390-
被引量:1
标识
DOI:10.1093/rheumatology/keag390
摘要
SSc is the rheumatic disease with the highest individual mortality rate and is associated with substantial morbidity that severely affects quality of life. Organ fibrosis is a major contributor to irreversible damage in SSc, whereas early inflammatory manifestations largely reflect disease activity and may still respond to early immunomodulatory treatment. New imaging modalities, as well as novel applications of established techniques-such as lung US or improved US assessment of synovial involvement-offer promising opportunities to objectively distinguish activity i.e. early inflammation and early fibrosis from damage (i.e. late irreversible fixed vasculopathy or fibrosis) at the organ level. Differentiating these processes is essential for refining the therapeutic window of opportunity in this rare but devastating disease. This narrative review aims to provide an up-to-date overview of available and emerging imaging tools that may help discriminate activity from damage across organ systems involved in SSc, with a specific focus on early fibrotic and inflammatory manifestations.
科研通智能强力驱动
Strongly Powered by AbleSci AI